Gordon H. Busenbark
Director of Finance/CFO bij Cianna Medical, Inc.
Profiel
Gordon H.
Busenbark is currently the Chief Financial Officer at Cianna Medical, Inc. He previously held positions as Director at Nventa Biopharmaceuticals Corp.
and Akela Pharma, Inc. He was also the Vice President-Global Quality at Baxter Healthcare Corp.
from 1998 to 2003 and the Chief Financial Officer at Encysive Pharmaceuticals, Inc. from 2007 to 2009.
Additionally, he served as the Chief Financial Officer at Xytis, Inc., Inspiration Biopharmaceuticals, Inc., and Immuno AG.
Mr. Busenbark received his undergraduate and MBA degrees from the University of Utah in 1979.
Actieve functies van Gordon H. Busenbark
Bedrijven | Functie | Begin |
---|---|---|
Cianna Medical, Inc.
Cianna Medical, Inc. Medical SpecialtiesHealth Technology Cianna Medical, Inc. manufactures and marketing equipment for the treatment of early-stage breast cancer in women. The firm’s products include SAVI, a breast brachytherapy applicator used for the delivery of radiation after lumpectomy surgery; and SAVI SCOUT, a surgical guidance system that uses real-time audible and visual indicators to give surgeons a precise way to target tissue during lumpectomy and excisional biopsy procedures. The company was founded in 2007 and is headquartered in Aliso Viejo, CA. | Director of Finance/CFO | - |
Eerdere bekende functies van Gordon H. Busenbark
Bedrijven | Functie | Einde |
---|---|---|
Xytis, Inc.
Xytis, Inc. BiotechnologyHealth Technology Xytis, Inc. was engaged in the development of central nervous system. The company was founded by Werner Tschollar in January 2006 and was headquartered in Irvine, CA. | Director of Finance/CFO | 01-10-2009 |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Director of Finance/CFO | 01-10-2009 |
Nventa Biopharmaceuticals Corp.
Nventa Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Nventa Biopharmaceuticals Corp. discovered, developed and commercialized stress protein-based therapeutic vaccines. The company was headquartered in Victoria, Canada. | Director/Board Member | 22-05-2009 |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | 01-01-2003 |
Immuno AG | Director of Finance/CFO | - |
Opleiding van Gordon H. Busenbark
University of Utah | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 8 |
---|---|
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Health Technology |
Nventa Biopharmaceuticals Corp.
Nventa Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Nventa Biopharmaceuticals Corp. discovered, developed and commercialized stress protein-based therapeutic vaccines. The company was headquartered in Victoria, Canada. | Health Technology |
Xytis, Inc.
Xytis, Inc. BiotechnologyHealth Technology Xytis, Inc. was engaged in the development of central nervous system. The company was founded by Werner Tschollar in January 2006 and was headquartered in Irvine, CA. | Health Technology |
Inspiration Biopharmaceuticals, Inc.
Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Inspiration Biopharmaceuticals, Inc. produces intravenous recombinant therapies and develops non-invasive applications. It offers its products for the hemophilia community. The company was founded by Scott Donnelly Martin and John Read Taylor, Jr. on April 28, 2006 and is headquartered in Boston, MA. | Health Technology |
Akela Pharma, Inc.
Akela Pharma, Inc. Pharmaceuticals: MajorHealth Technology Akela Pharma, Inc. operates as a drug development company, which develops and manufactures pharmaceutical formulations and drugs. The company operates as a specialty contract pharmaceutical formulation developer and clinical and commercial drug manufacturer for proprietary drug products through its wholly-owned subsidiary, PharmaForm LLC, a pharmaceutical intellectual property development company. It provides specialty contract services in the area of pharmaceutical dosage form development, preclinical, scale-up, clinical and commercial supply manufacturing, focusing on controlled release and bioavailability enhancement technologies, such as hot melt extrusion, spray drying and liquid filled capsules. Akela Pharma was founded on November 15, 1988 and is headquartered in Austin, TX. | Health Technology |
Cianna Medical, Inc.
Cianna Medical, Inc. Medical SpecialtiesHealth Technology Cianna Medical, Inc. manufactures and marketing equipment for the treatment of early-stage breast cancer in women. The firm’s products include SAVI, a breast brachytherapy applicator used for the delivery of radiation after lumpectomy surgery; and SAVI SCOUT, a surgical guidance system that uses real-time audible and visual indicators to give surgeons a precise way to target tissue during lumpectomy and excisional biopsy procedures. The company was founded in 2007 and is headquartered in Aliso Viejo, CA. | Health Technology |
Immuno AG |